These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24301055)

  • 1. Production of apolipoprotein C-III knockout rabbits using zinc finger nucleases.
    Yang D; Zhang J; Xu J; Zhu T; Fan Y; Fan J; Chen YE
    J Vis Exp; 2013 Nov; (81):e50957. PubMed ID: 24301055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.
    Yan H; Niimi M; Matsuhisa F; Zhou H; Kitajima S; Chen Y; Wang C; Yang X; Yao J; Yang D; Zhang J; Murakami M; Nakajima K; Wang Y; Liu E; Liang J; Chen YE; Fan J
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2095-2107. PubMed ID: 32757647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
    Ding Y; Wang Y; Zhu H; Fan J; Yu L; Liu G; Liu E
    Transgenic Res; 2011 Aug; 20(4):867-75. PubMed ID: 21120692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCA1 promotes the de novo biogenesis of apolipoprotein CIII-containing HDL particles in vivo and modulates the severity of apolipoprotein CIII-induced hypertriglyceridemia.
    Kypreos KE
    Biochemistry; 2008 Sep; 47(39):10491-502. PubMed ID: 18767813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII.
    Li H; Han Y; Qi R; Wang Y; Zhang X; Yu M; Tang Y; Wang M; Shu YN; Huang W; Liu X; Rodrigues B; Han M; Liu G
    Cardiovasc Res; 2015 Sep; 107(4):579-89. PubMed ID: 26160324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases.
    Flisikowska T; Thorey IS; Offner S; Ros F; Lifke V; Zeitler B; Rottmann O; Vincent A; Zhang L; Jenkins S; Niersbach H; Kind AJ; Gregory PD; Schnieke AE; Platzer J
    PLoS One; 2011; 6(6):e21045. PubMed ID: 21695153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein CIII and diabetes. Is there a link?
    Christopoulou E; Tsimihodimos V; Filippatos T; Elisaf M
    Diabetes Metab Res Rev; 2019 Mar; 35(3):e3118. PubMed ID: 30557902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
    Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM
    J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.
    Rocha NA; East C; Zhang J; McCullough PA
    Curr Atheroscler Rep; 2017 Nov; 19(12):62. PubMed ID: 29124482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in lipoprotein-associated apoC-III levels following volanesorsen therapy: phase 2 randomized trial results.
    Yang X; Lee SR; Choi YS; Alexander VJ; Digenio A; Yang Q; Miller YI; Witztum JL; Tsimikas S
    J Lipid Res; 2016 Apr; 57(4):706-13. PubMed ID: 26848137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease.
    Zheng C
    Curr Opin Lipidol; 2014 Feb; 25(1):35-9. PubMed ID: 24345989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Apolipoprotein CIII trials.
    Tramontano D; Bini S; D'Erasmo L; Arca M
    Curr Opin Lipidol; 2022 Dec; 33(6):309-318. PubMed ID: 36206093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice.
    Yingchun H; Yahong M; Jiangping W; Xiaokui H; Xiaohong Z
    Lipids Health Dis; 2018 Sep; 17(1):220. PubMed ID: 30223835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockout of exogenous EGFP gene in porcine somatic cells using zinc-finger nucleases.
    Watanabe M; Umeyama K; Matsunari H; Takayanagi S; Haruyama E; Nakano K; Fujiwara T; Ikezawa Y; Nakauchi H; Nagashima H
    Biochem Biophys Res Commun; 2010 Nov; 402(1):14-8. PubMed ID: 20875794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced high density lipoprotein cholesterol in severe hypertriglyceridemic ApoCIII transgenic mice via lowered hepatic ApoAI synthesis.
    Han Y; Qi R; Liu G
    Biochem Biophys Res Commun; 2015 Jul; 462(4):420-5. PubMed ID: 25969427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of targeted gene in porcine somatic cells using zinc-finger nuclease.
    Hisamatsu S; Sakaue M; Takizawa A; Kato T; Kamoshita M; Ito J; Kashiwazaki N
    Anim Sci J; 2015 Feb; 86(2):132-7. PubMed ID: 25187232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein CIII links dyslipidemia with atherosclerosis.
    Kawakami A; Yoshida M
    J Atheroscler Thromb; 2009 Mar; 16(1):6-11. PubMed ID: 19262004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families.
    Bochem AE; van Capelleveen JC; Dallinga-Thie GM; Schimmel AW; Motazacker MM; Tietjen I; Singaraja RR; Hayden MR; Kastelein JJ; Stroes ES; Hovingh GK
    Clin Genet; 2014 May; 85(5):433-40. PubMed ID: 23701270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.